ScholarWorks@Korea University: Noh, Ji Yun

Detailed Information

Noh, Ji Yun (노지윤)

College of Medicine (Department of Medical Science)

Research Area

Tel 02-2626-3055
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

COVID19:18||SARSCoV2:15||Influenza:6||vaccine:4||immunogenicity:3||Vaccination:3||Hantavirus:3||Safety:3||Epidemiology:3||Vaccine:3||Streptococcus agalactiae:3||Surveillance:2||Hantaan virus:2||influenza:2||influenza A virus:2||Korea:2||influenza vaccine:2||vaccination:2||variants of concern:2||Hemorrhagic fever with renal syndrome:2||capsular polysaccharide:2||Adverse Event:2||Seroprevalence:2||antiviral agents:2||opsonophagocytic killing assay:2||pneumonia:2||immunoassay:2||Cellular immunity:2||Republic of Korea:2||Low birth weight:1||Obesity:1||hospitalbased influenza morbidity and mortality (HIMM):1||H7N9 Virus:1||adults:1||burden of disease:1||corticosteroid:1||influenza vaccines:1||Hepatitis A virus:1||MF59 adjuvant:1||seroprevalence:1||humoral immunity:1||Communityacquired pneumonia:1||Pneumococcus:1||Ageusia:1||Health personnel:1||matrix metalloproteinase13:1||antibody:1||blade:1||lysis:1||Healthcare worker:1||Vaccine effectiveness:1||Omicron BA.2:1||recovered patient:1||Family hantaviridae:1||Liver Cirrhosis:1||severe dengue:1||cell culture techniques:1||Health survey:1||Physician:1||elderly:1||Human:1||varicella:1||inhalation:1||Communicable diseases:1||Middle East respiratory syndrome coronavirus:1||Hospital planning:1||atherosclerosis:1||Severity:1||CD8+ T cell:1||mortality:1||neutralizing activity:1||cytokine:1||Campylobacter:1||H5N1:1||perception:1||Streptococcus pneumoniae:1||Health surveys:1||Pneumococcal infections:1||varicella zoster virus:1||herpes zoster:1||enzymelinked immunosorbent assay:1||validation:1||Outbreaks:1||Control:1||Asymptomatic infection:1||Saliva:1||Viral Load:1||Immunity:1||reactogenicity:1||crossneutralization:1||Ritonavir:1||Preterm birth:1||Immunization:1||healthcare cost:1||Influenza A(H7N9) virus:1||hemophagocyticlymphohistiocytosis:1||human Influenza:1||clinical trial:1||influenza B virus:1||Acinetobacter baumannii:1||health education:1||emerging:1||Incidence:1||HIV:1||Pneumococcal conjugate vaccine:1||CP: Immunology:1||nucleic acid:1||Sarscov2:1||D614G:1||Omicron BA.1:1||T cell immune response:1||Lopinavir:1||Pregnancy:1||inactivated influenza vaccine:1||History:1||inactivated:1||pregnancy:1||Hospitalization:1||Risk factors:1||virus:1||magnetic beads:1||Influenzalike Illness:1||quadrivalent influenza vaccine:1||human:1||epidemics:1||Awareness:1||Pandemics:1||Social distancing:1||cellular immunity:1||Social Distancing:1||p38 mitogenactivated protein kinase:1||prognosis:1||Humoral immunity:1||Nanoparticle vaccine:1||ancestral:1||mRNA vaccine:1||Hydroxychloroquine:1||substitution:1||Biofilm:1||Antibacterial agents:1||Herpes zoster:1||Influenza vaccines:1||Pandemic:1||Arthritis:1||Immunogenicity:1||Anosmia:1||immunity:1||Chlorhexidine:1||Coronavirus Disease 2019:1||Endemic transition:1||memory cell:1||Covid19:1||Recombinant protein vaccine:1||incidence:1||Bacteremia:1||DNA vaccine:1||dengue hemorrhagic fever:1||pandemic:1||drug resistance:1||pneumococcal vaccination:1||longevity:1||Closecontact transmission:1||ciclesonide:1||Disease outbreaks:1||Mortality:1||Infection control:1||Seroepidemiology:1||GBS:1||group B streptococcus:1||MHC class I multimer:1||extraction:1||breakthrough infection:1||

STATISTICS: Total View :6,908,212; Today View :7,824

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE